[go: up one dir, main page]

NO20005431L - Gelerbare farmasoytiske preparater - Google Patents

Gelerbare farmasoytiske preparater

Info

Publication number
NO20005431L
NO20005431L NO20005431A NO20005431A NO20005431L NO 20005431 L NO20005431 L NO 20005431L NO 20005431 A NO20005431 A NO 20005431A NO 20005431 A NO20005431 A NO 20005431A NO 20005431 L NO20005431 L NO 20005431L
Authority
NO
Norway
Prior art keywords
weight
gellable
pharmaceutical preparations
active substance
phospholipid
Prior art date
Application number
NO20005431A
Other languages
English (en)
Other versions
NO20005431D0 (no
Inventor
Henri Vranckx
Michel Deleers
Domenico Fanara
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of NO20005431D0 publication Critical patent/NO20005431D0/no
Publication of NO20005431L publication Critical patent/NO20005431L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Flytende farmasøytisk preparat for kontrollert frigivelse av minst ett aktivt stoff omfattende: a) en terapeutisk effektiv mengde av minst ett aktivt stoff; b) il 55 vekt% fosfolipid; c) 16 til 72 vekt% av ett eller flere farmasøytisk akseptable løsningsmidler; og d) 4 til 52 vekt% av minst én fettsyre. Preparatet er kjennetegnet ved at det har den egenskap at det umiddelbart geléres i nærvær av en vandig fase. Fremgangsmåte for fremstilling av preparatene og deres anvendelse for behandling av et menneske eller dyr er også beskrevet.
NO20005431A 1998-04-30 2000-10-27 Gelerbare farmasoytiske preparater NO20005431L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE9800329A BE1011899A6 (fr) 1998-04-30 1998-04-30 Compositions pharmaceutiques gelifiables utilisables.
PCT/EP1999/002551 WO1999056725A1 (fr) 1998-04-30 1999-04-16 Compositions pharmaceutiques gelifiables

Publications (2)

Publication Number Publication Date
NO20005431D0 NO20005431D0 (no) 2000-10-27
NO20005431L true NO20005431L (no) 2000-12-19

Family

ID=3891230

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005431A NO20005431L (no) 1998-04-30 2000-10-27 Gelerbare farmasoytiske preparater

Country Status (25)

Country Link
US (3) US6464987B1 (no)
EP (2) EP1073414B1 (no)
JP (2) JP2002513748A (no)
KR (1) KR100567975B1 (no)
CN (1) CN1183901C (no)
AT (2) ATE219659T1 (no)
AU (2) AU3708599A (no)
BE (1) BE1011899A6 (no)
BG (1) BG64723B1 (no)
BR (1) BR9910066A (no)
CA (1) CA2330500C (no)
DE (2) DE69901951T2 (no)
DK (1) DK1073415T3 (no)
EA (1) EA002530B1 (no)
ES (2) ES2178430T3 (no)
HU (1) HU226556B1 (no)
ID (1) ID26221A (no)
IL (1) IL139113A0 (no)
IS (1) IS2354B (no)
NO (1) NO20005431L (no)
NZ (1) NZ507707A (no)
RS (1) RS50025B (no)
TR (1) TR200003158T2 (no)
WO (2) WO1999056725A1 (no)
ZA (1) ZA200005915B (no)

Families Citing this family (159)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1011899A6 (fr) * 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.
ATE252889T1 (de) 1998-08-19 2003-11-15 Skyepharma Canada Inc Injizierbare wässerige propofoldispersionen
US11026768B2 (en) 1998-10-08 2021-06-08 Align Technology, Inc. Dental appliance reinforcement
DE10024413A1 (de) * 2000-05-19 2001-12-06 Mika Pharma Gmbh Pharmazeutische und/oder kosmetische Zubereitung
DE10057769A1 (de) 2000-11-22 2002-05-23 Beiersdorf Ag Haarpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen
US6887487B2 (en) * 2001-10-19 2005-05-03 Idexx Laboratories, Inc. Injectable compositions for the controlled delivery of pharmacologically active compound
US6946137B2 (en) * 2001-10-19 2005-09-20 Idexx Laboratories, Inc. Methods for the controlled delivery of pharmacologically active compounds
MXPA04008906A (es) * 2002-03-12 2005-09-08 Ethypharm Sa Composicion que tiene propiedades gelificantes para el suministro prolongado de sustancias bioactivas.
FR2837099B1 (fr) * 2002-03-12 2005-03-18 Ethypharm Sa Composition a proprietes gelifiantes destinee a la delivrance prolongee de substances bio-actives
US8435942B2 (en) * 2002-05-31 2013-05-07 Transdermal Biotechnology, Inc. Methods for formulating stabilized insulin compositions
US20040018237A1 (en) 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
US20050031650A1 (en) * 2002-08-26 2005-02-10 Ethypharm Composition with gelling properties for the sustained delivery of bioactive substances
DE10255195A1 (de) * 2002-11-27 2004-06-09 Lipoid Gmbh Micellare wasserlösliche Konzentrate
ES2623881T3 (es) * 2003-11-07 2017-07-12 Camurus Ab Composiciones de lípidos y péptidos catiónicos
US20070232695A1 (en) * 2004-01-28 2007-10-04 Collegium Pharmaceutical, Inc. Gelled Periodontal Anesthetic Preparation
US9492245B2 (en) 2004-02-27 2016-11-15 Align Technology, Inc. Method and system for providing dynamic orthodontic assessment and treatment profiles
RU2288699C2 (ru) * 2004-03-23 2006-12-10 Дж. Б. Кемикалс Энд Фармасьютикалс Лимитед Гелевая композиция для лечения стоматологических заболеваний и способ ее получения
SG173326A1 (en) * 2004-06-04 2011-08-29 Camurus Ab Liquid depot formulations
GB0412530D0 (en) * 2004-06-04 2004-07-07 Camurus Ab Formulation
US7858115B2 (en) * 2004-06-24 2010-12-28 Idexx Laboratories Phospholipid gel compositions for drug delivery and methods of treating conditions using same
EP1804771A2 (en) * 2004-10-28 2007-07-11 Idexx Laboratories, Inc. Compositions for controlled delivery of pharmaceutically active compounds
US20060115782A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for coating a dental appliance
US20060115785A1 (en) 2004-11-30 2006-06-01 Chunhua Li Systems and methods for intra-oral drug delivery
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
ES2343641T3 (es) * 2005-01-14 2010-08-05 Camurus Ab Formulaciones bioadhesivas topicas.
US9649382B2 (en) * 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
EP1848403B8 (en) * 2005-01-14 2010-05-19 Camurus Ab Topical bioadhesive formulations
DE602005026998D1 (de) * 2005-01-14 2011-04-28 Camurus Ab Somatostatin-analog-formulierungen
KR100983746B1 (ko) * 2005-01-14 2010-09-24 카무러스 에이비 소마토스타틴 유사 제형
US9060935B2 (en) 2005-01-21 2015-06-23 Camurus Ab Pharmaceutical lipid compositions
ES2399645T3 (es) * 2005-06-06 2013-04-02 Camurus Ab Formulaciones de análogos de GLP-1
SE531318C2 (sv) * 2007-02-22 2009-02-24 Tigran Technologies Ab Publ Injicerbar suspension innefattande titan-,titanlegerings- eller titanoxidpartiklar av mikrostruktur
US7878805B2 (en) 2007-05-25 2011-02-01 Align Technology, Inc. Tabbed dental appliance
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
EP2200582B1 (fr) * 2007-09-12 2013-03-20 Galderma Research & Development Utilisation d'excipients en tant que conservateurs et composition pharmaceutique les comprenant
US8738394B2 (en) 2007-11-08 2014-05-27 Eric E. Kuo Clinical data file
FR2926996B1 (fr) 2008-01-31 2013-06-21 Ethypharm Sa Composition pharmaceutique a proprietes gelifiantes contenant un derive de tyrosine
US8108189B2 (en) 2008-03-25 2012-01-31 Align Technologies, Inc. Reconstruction of non-visible part of tooth
US8092215B2 (en) 2008-05-23 2012-01-10 Align Technology, Inc. Smile designer
US9492243B2 (en) 2008-05-23 2016-11-15 Align Technology, Inc. Dental implant positioning
US8172569B2 (en) 2008-06-12 2012-05-08 Align Technology, Inc. Dental appliance
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
US20110229565A1 (en) 2008-09-17 2011-09-22 Karp Jeffrey M Drug Delivery Composition Comprising a Self-Assembled Gelator
US8152518B2 (en) 2008-10-08 2012-04-10 Align Technology, Inc. Dental positioning appliance having metallic portion
US8292617B2 (en) 2009-03-19 2012-10-23 Align Technology, Inc. Dental wire attachment
US8728516B2 (en) * 2009-04-30 2014-05-20 Abbvie Inc. Stabilized lipid formulation of apoptosis promoter
US20100278921A1 (en) * 2009-04-30 2010-11-04 Fischer Cristina M Solid oral formulation of abt-263
US8362013B2 (en) * 2009-04-30 2013-01-29 Abbvie Inc. Salt of ABT-263 and solid-state forms thereof
US20100297194A1 (en) * 2009-04-30 2010-11-25 Nathaniel Catron Formulation for oral administration of apoptosis promoter
US20100280031A1 (en) * 2009-04-30 2010-11-04 Paul David Lipid formulation of apoptosis promoter
TWI532484B (zh) * 2009-06-08 2016-05-11 艾伯維有限公司 包含凋亡促進劑之固態分散劑
TWI471321B (zh) * 2009-06-08 2015-02-01 亞培公司 Ｂｃｌ－２族群抑制劑之口服醫藥劑型
RU2532027C2 (ru) * 2009-07-24 2014-10-27 Мика Фарма Гезельшафт Фюр Ди Энтвиклюнг Унд Фермарктунг Фармацойтишер Продукте Мбх Жидкие композиции, способные к пенообразованию и включающие активные средства, и способы их получения и разработки
US8765031B2 (en) 2009-08-13 2014-07-01 Align Technology, Inc. Method of forming a dental appliance
CA2780177A1 (en) * 2009-12-22 2011-06-30 Abbott Laboratories Abt-263 capsule
AU2011223730A1 (en) * 2010-03-02 2012-10-18 Imagenetix, Inc. Compositions comprising myristic acid and uses thereof
US9241774B2 (en) 2010-04-30 2016-01-26 Align Technology, Inc. Patterned dental positioning appliance
US9211166B2 (en) 2010-04-30 2015-12-15 Align Technology, Inc. Individualized orthodontic treatment index
JP2013540757A (ja) 2010-09-24 2013-11-07 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド カプセル化された作用物質の放出を制御する能力を有するナノ構造ゲル
UA113500C2 (xx) 2010-10-29 2017-02-10 Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб
EP2685962A1 (en) 2011-03-17 2014-01-22 Transdermal Biotechnology, Inc. Topical nitric oxide systems and methods of use thereof
EP2699267A4 (en) * 2011-04-18 2014-11-12 Lipidor Ab LIQUID CARRIER FOR THE ORAL DELIVERY OF A PHARMACOLOGICAL ACTIVE SUBSTANCE
US9403238B2 (en) 2011-09-21 2016-08-02 Align Technology, Inc. Laser cutting
US8716363B2 (en) * 2011-09-28 2014-05-06 Globus Medical, Inc. Biodegradable putty compositions and implant devices, methods, and kits relating to the same
AU2012348640B2 (en) * 2011-12-05 2016-07-21 Camurus Ab Robust controlled-release peptide formulations
EP2793606A1 (en) * 2011-12-21 2014-10-29 Hill's Pet Nutrition, Inc. Treatment or reduction of dental conditions with ascorbyl esters
US9375300B2 (en) 2012-02-02 2016-06-28 Align Technology, Inc. Identifying forces on a tooth
US9220580B2 (en) 2012-03-01 2015-12-29 Align Technology, Inc. Determining a dental treatment difficulty
AU2013257546B2 (en) 2012-05-10 2017-12-14 Painreform Ltd. Depot formulations of a local anesthetic and methods for preparation thereof
US9414897B2 (en) 2012-05-22 2016-08-16 Align Technology, Inc. Adjustment of tooth position in a virtual dental model
IN2014DN09831A (no) 2012-05-25 2015-08-07 Camurus Ab
PL2877155T3 (pl) 2012-07-26 2021-05-17 Camurus Ab Formulacje opioidowe
LT2877155T (lt) 2012-07-26 2021-02-25 Camurus Ab Opioidų vaisto formos
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9610141B2 (en) 2014-09-19 2017-04-04 Align Technology, Inc. Arch expanding appliance
US10449016B2 (en) 2014-09-19 2019-10-22 Align Technology, Inc. Arch adjustment appliance
US9744001B2 (en) 2014-11-13 2017-08-29 Align Technology, Inc. Dental appliance with cavity for an unerupted or erupting tooth
US10504386B2 (en) 2015-01-27 2019-12-10 Align Technology, Inc. Training method and system for oral-cavity-imaging-and-modeling equipment
US9610242B2 (en) 2015-08-18 2017-04-04 Concept Labs, Inc. Water-gel emulsion compositions and methods
US9962339B2 (en) 2015-10-08 2018-05-08 The Brigham And Women's Hospital, Inc. Stabilized assembled nanostructures for delivery of encapsulated agents
US11554000B2 (en) 2015-11-12 2023-01-17 Align Technology, Inc. Dental attachment formation structure
US11931222B2 (en) 2015-11-12 2024-03-19 Align Technology, Inc. Dental attachment formation structures
US11103330B2 (en) 2015-12-09 2021-08-31 Align Technology, Inc. Dental attachment placement structure
US11596502B2 (en) 2015-12-09 2023-03-07 Align Technology, Inc. Dental attachment placement structure
EP3978022A1 (en) 2016-05-06 2022-04-06 The Brigham and Women's Hospital, Inc. Binary self assembled gels for controlled delivery of encapsulated agents to cartilage
EP3471599B1 (en) 2016-06-17 2025-11-19 Align Technology, Inc. Intraoral appliances with sensing
EP3988048B1 (en) 2016-06-17 2024-01-17 Align Technology, Inc. Orthodontic appliance performance monitor
CN115869098A (zh) 2016-07-27 2023-03-31 阿莱恩技术有限公司 具有牙科诊断能力的口内扫描仪
WO2018085718A2 (en) 2016-11-04 2018-05-11 Align Technology, Inc. Methods and apparatuses for dental images
PL3547952T3 (pl) 2016-12-02 2021-05-31 Align Technology, Inc. Ekspander podniebienny
US11026831B2 (en) 2016-12-02 2021-06-08 Align Technology, Inc. Dental appliance features for speech enhancement
WO2018102770A1 (en) 2016-12-02 2018-06-07 Align Technology, Inc. Force control, stop mechanism, regulating structure of removable arch adjustment appliance
WO2018102811A1 (en) 2016-12-02 2018-06-07 Align Technology, Inc. Methods and apparatuses for customizing rapid palatal expanders using digital models
US10548700B2 (en) 2016-12-16 2020-02-04 Align Technology, Inc. Dental appliance etch template
WO2018144991A1 (en) 2017-02-03 2018-08-09 The Brigham And Women's Hospital, Inc. Self-assembled gels formed with anti-retroviral drugs, prodrugs thereof, and pharmaceutical uses thereof
US10779718B2 (en) 2017-02-13 2020-09-22 Align Technology, Inc. Cheek retractor and mobile device holder
WO2018183358A1 (en) 2017-03-27 2018-10-04 Align Technology, Inc. Apparatuses and methods assisting in dental therapies
US10613515B2 (en) 2017-03-31 2020-04-07 Align Technology, Inc. Orthodontic appliances including at least partially un-erupted teeth and method of forming them
US10881745B2 (en) 2017-05-08 2021-01-05 Alivio Therapeutics, Inc. Formulation of nanostructured gels for increased agent loading and adhesion
US11045283B2 (en) 2017-06-09 2021-06-29 Align Technology, Inc. Palatal expander with skeletal anchorage devices
CN110769777B (zh) 2017-06-16 2023-08-11 阿莱恩技术有限公司 牙齿类型和萌出状态的自动检测
WO2019005808A1 (en) 2017-06-26 2019-01-03 Align Technology, Inc. BIOCAPTOR PERFORMANCE INDICATOR FOR INTRABUCCAL DEVICES
US10885521B2 (en) 2017-07-17 2021-01-05 Align Technology, Inc. Method and apparatuses for interactive ordering of dental aligners
WO2019018784A1 (en) 2017-07-21 2019-01-24 Align Technology, Inc. ANCHOR OF CONTOUR PALATIN
EP3658070B1 (en) 2017-07-27 2025-11-26 Align Technology, Inc. Tooth shading, transparency and glazing
EP3658067B1 (en) 2017-07-27 2023-10-25 Align Technology, Inc. System and methods for processing an orthodontic aligner by means of an optical coherence tomography
US12274597B2 (en) * 2017-08-11 2025-04-15 Align Technology, Inc. Dental attachment template tray systems
WO2019035979A1 (en) 2017-08-15 2019-02-21 Align Technology, Inc. EVALUATION AND CALCULATION OF BUCCAL CORRIDOR
US11123156B2 (en) 2017-08-17 2021-09-21 Align Technology, Inc. Dental appliance compliance monitoring
WO2019071019A1 (en) 2017-10-04 2019-04-11 Align Technology, Inc. INTRAORAL APPARATUS FOR SAMPLING MOUTH TISSUE
US10813720B2 (en) 2017-10-05 2020-10-27 Align Technology, Inc. Interproximal reduction templates
CN111565668B (zh) 2017-10-27 2022-06-07 阿莱恩技术有限公司 替代咬合调整结构
CN111295153B (zh) 2017-10-31 2023-06-16 阿莱恩技术有限公司 具有选择性牙合负荷和受控牙尖交错的牙科器具
EP4545041A3 (en) 2017-11-01 2025-07-09 Align Technology, Inc. Automatic treatment planning
US11534974B2 (en) 2017-11-17 2022-12-27 Align Technology, Inc. Customized fabrication of orthodontic retainers based on patient anatomy
CN118948478A (zh) 2017-11-30 2024-11-15 阿莱恩技术有限公司 用于监测口腔矫治器的传感器
WO2019118876A1 (en) 2017-12-15 2019-06-20 Align Technology, Inc. Closed loop adaptive orthodontic treatment methods and apparatuses
US10980613B2 (en) 2017-12-29 2021-04-20 Align Technology, Inc. Augmented reality enhancements for dental practitioners
EP3743010B1 (en) 2018-01-26 2022-01-12 Align Technology, Inc. Diagnostic intraoral scanning and tracking
US11937991B2 (en) 2018-03-27 2024-03-26 Align Technology, Inc. Dental attachment placement structure
CN108498376B (zh) * 2018-04-02 2020-11-13 榛硕（武汉）智能科技有限公司 一种甲基硅油乳液及其制备方法
AU2019251474B2 (en) 2018-04-11 2024-09-12 Align Technology, Inc. Releasable palatal expanders
US11839605B2 (en) 2018-10-11 2023-12-12 Alivio Therapeutics, Inc. Non-injectable hydrogel formulations for smart release
US20210346302A1 (en) 2018-10-15 2021-11-11 Cipla Limited Pharmaceutical Formulation
EP3848016A1 (en) * 2020-01-08 2021-07-14 3M Innovative Properties Company Oral care composition containing fatty acid components for treating caries
US11992483B2 (en) 2021-03-31 2024-05-28 Cali Biosciences Us, Llc Emulsions for local anesthetics
JP7092922B1 (ja) 2021-06-11 2022-06-28 キユーピー株式会社 製剤
WO2025110709A1 (ko) * 2023-11-22 2025-05-30 엠엑스바이오 주식회사 치주 질환의 예방 또는 치료용 조성물 및 치과용 복합 항생제 연고 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5230899A (en) * 1985-08-07 1993-07-27 Smithkline Beecham Corporation Methods and compositions for making liposomes
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US5230895A (en) * 1990-05-01 1993-07-27 Copley Pharmaceutical Inc. Sustained released delivery system for use in the periodontal pocket
US5567456A (en) * 1991-11-04 1996-10-22 Creative Products Inc. Of Rossville Food release compositions with organic fluidizing agents
CA2082561A1 (en) * 1991-11-12 1993-05-13 Francis J. Leng Antiperspirant materials and compositions
JP3190441B2 (ja) * 1992-07-20 2001-07-23 エーザイ株式会社 塩酸アゼラスチンを含有する安定な製剤
GB9224010D0 (en) * 1992-11-16 1993-01-06 Phares Pharma Holland Composition and method
AU7343894A (en) 1993-07-28 1995-02-28 University Of Saskatchewan Biphasic multilamellar lipid vesicles
ES2180599T3 (es) * 1994-09-30 2003-02-16 Mika Pharma Ges Fur Die Entwic Composicion farmaceutica.
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
BE1011899A6 (fr) * 1998-04-30 2000-02-01 Ucb Sa Compositions pharmaceutiques gelifiables utilisables.

Also Published As

Publication number Publication date
NO20005431D0 (no) 2000-10-27
DE69901951D1 (de) 2002-08-01
YU66600A (sh) 2003-04-30
AU4030899A (en) 1999-11-23
ES2249891T3 (es) 2006-04-01
WO1999056725A1 (fr) 1999-11-11
HK1033263A1 (en) 2001-08-24
US6818224B2 (en) 2004-11-16
DE69901951T2 (de) 2002-11-28
AU738455B2 (en) 2001-09-20
EP1073415B1 (fr) 2005-10-26
DK1073415T3 (da) 2006-03-06
TR200003158T2 (tr) 2001-03-21
ATE219659T1 (de) 2002-07-15
JP2002513748A (ja) 2002-05-14
JP2002513749A (ja) 2002-05-14
HUP0101580A2 (hu) 2002-03-28
EA002530B1 (ru) 2002-06-27
HUP0101580A3 (en) 2002-10-28
DE69927963T2 (de) 2006-06-29
RS50025B (sr) 2008-11-28
IS2354B (is) 2008-04-15
BG104872A (bg) 2001-07-31
ES2178430T3 (es) 2002-12-16
IL139113A0 (en) 2001-11-25
BG64723B1 (bg) 2006-01-31
ATE307569T1 (de) 2005-11-15
EP1073415A1 (fr) 2001-02-07
CN1301147A (zh) 2001-06-27
CA2330500A1 (fr) 1999-11-11
BE1011899A6 (fr) 2000-02-01
CA2330500C (fr) 2009-06-16
EP1073414B1 (fr) 2002-06-26
KR20010043000A (ko) 2001-05-25
US6464987B1 (en) 2002-10-15
US20030199477A1 (en) 2003-10-23
CN1183901C (zh) 2005-01-12
ID26221A (id) 2000-12-07
US6471970B1 (en) 2002-10-29
ZA200005915B (en) 2001-10-23
KR100567975B1 (ko) 2006-04-07
EP1073414A1 (fr) 2001-02-07
HU226556B1 (en) 2009-03-30
AU3708599A (en) 1999-11-23
IS5669A (is) 2000-10-17
WO1999056726A1 (fr) 1999-11-11
NZ507707A (en) 2002-05-31
EA200001125A1 (ru) 2001-04-23
BR9910066A (pt) 2000-12-26
DE69927963D1 (de) 2005-12-01

Similar Documents

Publication Publication Date Title
NO20005431L (no) Gelerbare farmasoytiske preparater
CA2159985C (en) Methods of using hesperetin for sebum control and treatment of acne
EP1024808A1 (en) Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
YU126186A (en) Process for making water gelating solutions of arylpropionic acid derivatives, which can be respirated through skin
CZ293665B6 (cs) Prostředek pro místní podání
JP4359140B2 (ja) 異常な角質性物質を除去するための製剤
SE453259B (sv) Kosmetiskt preparat med formaga till aterbildning av hud- och muskelvevnad
JPH07215848A (ja) 皮膚外用剤及び皮膚化粧料
NO996438L (no) Ny kombinasjon av antiastmamedikamenter
NO166569C (no) Fremgangsmaate til fremstilling av farmasoeytisk preparat inneholdende fosfolipider og ikke-steroidale antiflogistika.
US5444076A (en) Pharmaceutical preparation for topical application
NO911021L (no) Fremgangsmaate og preparat for iontoforese.
US20190125648A1 (en) Composition for preventing, improving or treating hair loss comprising deoxycholic acid as active ingredient
MY101266A (en) Pharmaceutical formulations
JPS5839616A (ja) 消炎鎮痛軟膏剤
KR100444102B1 (ko) 백자인 추출물 함유 발모촉진용 화장료 조성물
JP3909008B2 (ja) 角化酵素阻害剤及びそれを含有してなる皮膚外用剤
JPS59155306A (ja) 発毛促進剤
CA1142090A (en) Topical anti-inflammatory composition
RU2029543C1 (ru) Лосьон для ухода за кожей лица и головы
JPH06321971A (ja) 新規なアルカロイド誘導体、その使用およびそれを含む医薬処方組成物
ITGE980004A1 (it) Composizione per il trattamento cosmetico topico della cellulite.
JPS60208907A (ja) 毛髪成長刺激剤
JPH0449216A (ja) メラニン抑制剤
JPH04221305A (ja) 皮膚外用剤

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application